Search research articles
Contact Us
Filters
Showing results (41-50 of 86) with videos related to
Page
of 9
Sort By:
European Journal of Pharmacology
|
August 15, 1978
3H-Spiroperidol binding to two receptor sites in both the corpus striatum and frontal cortex of rat brain
N W Pedigo, T D Reisine, J Z Fields, et al.
Alcohol and Drug Research
|
January 1, 1987
Cyclo (Leu-Gly) attenuates the striatal dopaminergic supersensitivity induced by chronic morphine
J M Lee, F DeLeon-Jones, J Z Fields, et al.
Neuropharmacology
|
September 1, 1986
Evaluation of ciladopa hydrochloride as a potential anti-Parkinson drug
W C Koller, J Z Fields, J H Gordon, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
April 19, 2002
PKC-zeta is required in EGF protection of microtubules and intestinal barrier integrity against oxidant injury
A Banan, J Z Fields, D A Talmage, et al.
The American Journal of Gastroenterology
|
March 1, 1994
Increased gastrointestinal symptoms in chronic alcoholics
J Z Fields, A Turk, M Durkin, et al.
Anticancer Research
|
August 10, 2002
Development of cross-resistance to tamoxifen in raloxifene-treated breast carcinoma cells
Z O Gao, Z P Gao, J Z Fields, et al.
Archives of Biochemistry and Biophysics
|
May 1, 1992
Inhibition of mitochondrial succinate oxidation--similarities and differences between N-methylated beta-carbolines and MPP+
J Z Fields, R R Albores, E J Neafsey, et al.
Alcoholism, Clinical and Experimental Research
|
April 1, 1996
Human neutrophil functions are inhibited in vitro by clinically relevant ethanol concentrations
M Patel, A Keshavarzian, V Kottapalli, et al.
Pharmacology, Biochemistry, and Behavior
|
December 1, 1991
Long-lasting dopamine receptor up-regulation in amphetamine-treated rats following amphetamine neurotoxicity
J Z Fields, L Wichlinski, G E Drucker, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 20, 2003
Evidence that nuclear factor-kappa B activation is critical in oxidant-induced disruption of the microtubule cytoskeleton and barrier integrity and that its inactivation is essential in epidermal growth factor-mediated protection of the monolayers of intestinal epithelia
A Banan, A Farhadi, J Z Fields, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 86) with videos related to
Sort By:
Page
of 9
European Journal of Pharmacology
|
August 15, 1978
3H-Spiroperidol binding to two receptor sites in both the corpus striatum and frontal cortex of rat brain
N W Pedigo, T D Reisine, J Z Fields, et al.
Alcohol and Drug Research
|
January 1, 1987
Cyclo (Leu-Gly) attenuates the striatal dopaminergic supersensitivity induced by chronic morphine
J M Lee, F DeLeon-Jones, J Z Fields, et al.
Neuropharmacology
|
September 1, 1986
Evaluation of ciladopa hydrochloride as a potential anti-Parkinson drug
W C Koller, J Z Fields, J H Gordon, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
April 19, 2002
PKC-zeta is required in EGF protection of microtubules and intestinal barrier integrity against oxidant injury
A Banan, J Z Fields, D A Talmage, et al.
The American Journal of Gastroenterology
|
March 1, 1994
Increased gastrointestinal symptoms in chronic alcoholics
J Z Fields, A Turk, M Durkin, et al.
Anticancer Research
|
August 10, 2002
Development of cross-resistance to tamoxifen in raloxifene-treated breast carcinoma cells
Z O Gao, Z P Gao, J Z Fields, et al.
Archives of Biochemistry and Biophysics
|
May 1, 1992
Inhibition of mitochondrial succinate oxidation--similarities and differences between N-methylated beta-carbolines and MPP+
J Z Fields, R R Albores, E J Neafsey, et al.
Alcoholism, Clinical and Experimental Research
|
April 1, 1996
Human neutrophil functions are inhibited in vitro by clinically relevant ethanol concentrations
M Patel, A Keshavarzian, V Kottapalli, et al.
Pharmacology, Biochemistry, and Behavior
|
December 1, 1991
Long-lasting dopamine receptor up-regulation in amphetamine-treated rats following amphetamine neurotoxicity
J Z Fields, L Wichlinski, G E Drucker, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 20, 2003
Evidence that nuclear factor-kappa B activation is critical in oxidant-induced disruption of the microtubule cytoskeleton and barrier integrity and that its inactivation is essential in epidermal growth factor-mediated protection of the monolayers of intestinal epithelia
A Banan, A Farhadi, J Z Fields, et al.
Page
of 9